RU95121732A - APPLICATION OF LAMOTrigine FOR THE TREATMENT OF NEURO-AIDS AND THE METHOD FOR PRODUCING A MEDICINE - Google Patents

APPLICATION OF LAMOTrigine FOR THE TREATMENT OF NEURO-AIDS AND THE METHOD FOR PRODUCING A MEDICINE

Info

Publication number
RU95121732A
RU95121732A RU95121732/14A RU95121732A RU95121732A RU 95121732 A RU95121732 A RU 95121732A RU 95121732/14 A RU95121732/14 A RU 95121732/14A RU 95121732 A RU95121732 A RU 95121732A RU 95121732 A RU95121732 A RU 95121732A
Authority
RU
Russia
Prior art keywords
lamotrigine
treatment
neuro
aids
medicine
Prior art date
Application number
RU95121732/14A
Other languages
Russian (ru)
Inventor
БУССО Анн
ДОУБЛ Адам
Лувель Эрик
Original Assignee
Рон-Пуленк Роре С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рон-Пуленк Роре С.А. filed Critical Рон-Пуленк Роре С.А.
Publication of RU95121732A publication Critical patent/RU95121732A/en

Links

Claims (4)

1. Применение ламотригина или фармацевтически приемлемых солей этого соединения для получения лекарственных средств, предназначенных для лечения нейро-СПИДА.1. The use of lamotrigine or pharmaceutically acceptable salts of this compound for the manufacture of drugs for the treatment of neuro-AIDS. 2. Применение по п. 1 для получения лекарственных средств, предназначенных для лечения умственных нарушений, нарушений способности к познанию, невропатии, миопатий, расстройств зрения и любых неврологических симптомов, связанных о вирусом ВИЧ-1. 2. The use according to claim 1 for the manufacture of medicines for the treatment of mental disorders, cognitive impairment, neuropathy, myopathy, visual impairment and any neurological symptoms associated with the HIV-1 virus. 3. Применение по п. 1 для получения лекарственного средства, содержащего 25-200 мг ламотригина. 3. The use of claim 1 for the manufacture of a medicament containing 25-200 mg of lamotrigine. 4. Способ получения лекарственного средства, полезного для лечения нейро-СПИДА, отличающийся тем, что смешивают ламотригин или фармацевтически приемлемую соль этого соединения с одним или несколькими разбавителями и/или вспомогательными веществами, совместимыми и фармацевтически приемлемыми. 4. A method of obtaining a medicinal product useful for the treatment of neuro-AIDS, characterized in that lamotrigine or a pharmaceutically acceptable salt of this compound is mixed with one or more diluents and / or excipients, compatible and pharmaceutically acceptable.
RU95121732/14A 1993-03-05 1994-02-25 APPLICATION OF LAMOTrigine FOR THE TREATMENT OF NEURO-AIDS AND THE METHOD FOR PRODUCING A MEDICINE RU95121732A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9302568 1993-03-05

Publications (1)

Publication Number Publication Date
RU95121732A true RU95121732A (en) 1997-10-10

Family

ID=

Similar Documents

Publication Publication Date Title
RU95121731A (en) APPLICATION OF RILUZOL FOR THE TREATMENT OF NEURO AIDS AND THE METHOD FOR PRODUCING A MEDICINE
RU95114405A (en) USE OF RILUZOL AS A MEDICINAL PRODUCT FOR TREATMENT OF NEUROLOGICAL DISORDERS CAUSED BY INJURIES AND METHOD FOR PRODUCING A MEDICINE
KR960700716A (en) USE OF RILUZOLE FOR TREATING AIDS-RELATED NEURAL DISORDERS
MX9203543A (en) MEDICINE.
KR930007441A (en) medicine
ATE292463T1 (en) L-CARNITINE OR DERIVATIVES THEREOF AND RESVERATROL OR DERIVATIVES THEREOF FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES, PERIPHERAL VASCULAR DISEASE, PERIPHERAL DIABETIC NEUROPATHY AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
US4435449A (en) Treatment of minimal brain dysfunction (MBD)
BR9306841A (en) Pharmaceutical composition process for providing an antihistamine treatment which does not induce any significant cardiac arrhythmia in a human patient and use of a composition for the manufacture of a medicine for use in an antihistamine treatment
HUP0203325A2 (en) Bicyclic amino acids, pharmaceutical compositions containing them and their use
CA2004239A1 (en) Use of acetyl d-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment
ES2173111T3 (en) USE OF FENSERINE FOR THE PREPARATION OF MEDICINES FOR THE TREATMENT OF COGNOSCITIVE DISORDERS.
RU95101385A (en) Products containing g-csf and tnf-binding protein
JP3018160B2 (en) Drug for reducing dysmenorrhea and / or premenstrual syndrome
US5011841A (en) Treatment of depression
EP0600582B1 (en) Treatment for muscular dystrophy
RU95121732A (en) APPLICATION OF LAMOTrigine FOR THE TREATMENT OF NEURO-AIDS AND THE METHOD FOR PRODUCING A MEDICINE
ATE159427T1 (en) USE OF THE N-N-BUTYL DERIVATIVE OF DESOXYNOJIRIMYCIN FOR THE PRODUCTION OF A MEDICINE FOR INHIBITING HIV VIRUS
US3903301A (en) Methods of treating muscular disorders
RU97104062A (en) APPLICATION OF SELEGYLIN FOR TREATMENT OF EPILEPTIC DISEASES
DE3821392A1 (en) NEW PHARMACEUTICAL USE OF 2-PHENYL-1,2-BENZISOSELENAZOLE-3 (2H) -ONEONE (EBSELEN)
KR910007528A (en) Use of Benzodiazepines and Phenylpyrylketone Derivatives
DE345883T1 (en) USE OF DAPIPRAZOLE FOR PRODUCING A MEDICINAL PRODUCT TO PREVENT TOLERANCE DEVELOPMENT IN ANALGETIC TREATMENT WITH MORPHINE.
RU95115404A (en) APPLICATION OF RILUZOLE AS A MEANS FOR THE TREATMENT OF PARKINSON'S DISEASE AND PARKINSON'S SYNDROMES, METHOD FOR PRODUCING A MEDICINE
US5081129A (en) Method of treatment of anemia with seratonin antagonists
IE55181B1 (en) Treatment of minimal brain dysfunction(mbd)